Enhanced transformation and chemosensitivity of NIH3T3 cells transduced with hepatoma up-regulated protein

Biochemical and Biophysical Research Communications

Volumn 340, Issue 1, 2006, Pages 244-249

  Wang, Yu Chun ^a   Lee, Ying Huei ^a   Huang, Guan Cheng ^a   Lin, Yu Hsuan ^a   Fan Chiang, Mei Huei ^a   Chiu, Allen W ^a,b   Huang, Yu Lun ^a  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b Zhongxiao Municipal Hospital   (Taiwan)

Author keywords

Anticancer drugs; Chemosensitivity; HURP; Transformation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AGAROSE; CARBOPLATIN; CISPLATIN; CYTARABINE; CYTOSINE DERIVATIVE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; HEPATOMA UP REGULATED PROTEIN; INTERCALATING AGENT; PACLITAXEL; PROTEIN; UNCLASSIFIED DRUG; VINBLASTINE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL STRAIN 3T3; CHEMOSENSITIVITY; COLONY FORMATION; CONTROLLED STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; LETHAL DOSE 50; MICE; NEOPLASM PROTEINS; NIH 3T3 CELLS; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

ANIMALIA;

EID: 29244455619     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.12.005     Document Type: Article

References (24)

1. B. Vogelstein, E.R. Fearon, S.R. Hamilton, S.E. Kern, A.C. Preisinger, and M. Leppert Genetic alterations during colorectal tumor development New Engl. J. Med. 319 1988 525 532
2. B. Vogelstein, and K.W. Kinzler The multistep nature of cancer Trends Genet. 9 1993 138 141
3. I.B. Weinstein Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis Carcinogenesis 21 2000 857 858
4. R. Weinberg Oncogenes and tumor suppressor genes, CA Cancer J. Clin. 44 1994 160 170
5. K. Munger Disruption of oncogene/tumor suppressor networks during human carcinogenesis Cancer Invest. 20 2002 71 81
6. A.P. Tsou, C.W. Yang, C.Y.F. Huang, R.C.T. Yu, Y.C.G. Lee, C.W. Chang, B.R. Chen, Y.F. Chung, M.J. Fann, C.W. Chi, J.H. Chiu, and C.K. Chou Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma Oncogene 22 2003 298 307
7. A.W. Chiu, Y.L. Huang, S.K. Huan, Y.C. Wang, J.P. Ju, M.F. Chen, and C.K. Chou Potential molecular marker for detecting transitional cell carcinoma Urology 60 2002 181 185
8. Y.L. Huang, A.W. Chiu, S.K. Huan, Y.C. Wang, J.P. Ju, and C.L. Lu Prognostic significance of hepatoma up-regulated protein expression in patients with urinary bladder transitional cell carcinoma Anticancer Res. 23 2003 2729 2734
9. D.A. Scudiero, R.H. Shoemaker, K.D. Paull, A. Monks, S. Tierney, T.H. Nofziger, M.J. Currens, D. Seniff, and M.R. Boyd Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines Cancer Res. 48 1988 4827 4833
10. S. Bassal, N. Nomura, D. Venter, K. Brand, M.J. McKay, and P.J. van der Spek Characterization of a novel human cell-cycle-regulated homologue of Drosophila dlg1 Genomics 77 2001 5 7
11. D.Y. Bouffard, L.F. Momparler, and R.L. Momparler Comparison of the antineoplastic activity of 2′,2′-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells Anticancer Drugs 2 1991 49 55
12. D.Y. Bouffard, and R.L. Momparler Comparison of the induction of apoptosis in human leukemic cell lines by 2′,2′- difluorodeoxycytidine (gemcitabine) and cytosine arabinoside Leuk. Res. 19 1995 849 856
13. V.W. Ruiz van Haperen, G. Veerman, J.B. Vermorken, and G.J. Peters 2′,2′-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines Biochem Pharmacol. 46 1993 762 766
14. P. Huang, S. Chubb, L.W. Hertel, G.B. Grindey, and W. Plunkett Action of 2′,2′-difluorodeoxycytidine on DNA synthesis Cancer Res. 51 1991 6110 6117
15. V. Heinemann, Y.Z. Xu, S. Chubb, A. Sen, L.W. Hertel, G.B. Grindey, and W. Plunkett Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine Mol. Pharmacol. 38 1990 567 572
16. V. Heinemann, Y.Z. Xu, S. Chubb, A. Sen, L.W. Hertel, G.B. Grindey, and W. Plunkett Cellular elimination of 2′,2′-difluorodeoxycytidine 5′-triphosphate: a mechanism of self-potentiation Cancer Res. 52 1992 533 539
17. Y. Manome, P.Y. Wen, Y. Dong, T. Tanaka, B.S. Mitchell, D.W. Kufe, and H.A. Fine Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo Nat. Med. 2 1996 567 573
18. C.M. Beausejour, J. Gagnon, M. Primeau, and R.L. Momparler Cytotoxic activity of 2′,2′-difluorodeoxycytidine, 5-aza-2′- deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene Biochem. Biophys. Res. Commun. 293 2002 1478 1484
19. V. Heinemann, L.W. Hertel, G.B. Grindey, and W.C. Plunkett Comparison of the cellular pharmacokinetics and toxicity of 2′,2′- difluorodeoxycytidine and 1-β-d-arabinofuranosylcytosine Cancer Res. 48 1988 4024 4031
20. B.A. Chabner, D.G. Johns, C.N. Coleman, J.C. Drake, and W.H. Evans Purification and properties of cytidine deaminase from normal and leukemic granulocytes J. Clin. Invest. 53 1974 922 931
21. C.D. Steuart, and P.J. Burke Cytidine deaminase and the development of resistance to arabinosyl cytosine Nat. New Biol. 233 1971 109 110
22. D.H. Ho Distribution of kinase and deaminase of 1-β-d- arabinofuranosylcytosine in tissues of man and mouse Cancer Res. 33 1973 2816 2820
23. R.L. Momparler, N. Eliopoulos, V. Bovenzi, S. Letourneau, M. Greenbaum, and D. Cournoyer Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells Cancer Gene Ther. 3 1996 331 338
24. R.W. Stam, M.L. den Boer, J.P. Meijerink, M.E. Ebus, G.J. Peters, P. Noordhuis, G.E. Janka-Schaub, S.A. Armstrong, S.J. Korsmeyer, and R. Pieters Differential mRNA expression of ARA-C-metabolizing enzymes explains ARA-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia Blood 101 2003 1270 1276